Health Canada Suspends Allergan's Licences For Its Biocell Breast Implants After Safety Review Concludes An Increased Risk Of Cancer
Summary Health Canada has suspended the licenses for Allergan's Biocell breast implants after determining they carry an increased risk of cancer. These implants were distributed across Canada. The suspension applies to this specific type of implant manufactured by Allergan.
- Reason
- Product safety
- Category
- consumer product recall
- Country
- Canada
- Agency
- HC-PRODUCTS
- Recall date
- 2019-05-28
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-PRODUCTS
Recall details on Nibble Recalls: https://trynibble.app/recalls/5bdca4c1-1610-4428-9388-70cea4fcffcc